| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10007062 | HBV | ENSG00000277893.2 | protein_coding | SRD5A2 | No | No | 6716 | P31213 |
| TVIS20054347 | HPV | ENSG00000277893.2 | protein_coding | SRD5A2 | No | No | 6716 | P31213 |
| TVIS20032353 | HPV | ENSG00000277893.2 | protein_coding | SRD5A2 | No | No | 6716 | P31213 |
| TVIS20041692 | HPV | ENSG00000277893.2 | protein_coding | SRD5A2 | No | No | 6716 | P31213 |
| TVIS44015870 | HTLV-1 | ENSG00000277893.2 | protein_coding | SRD5A2 | No | No | 6716 | P31213 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SRD5A2 |
|---|---|
| DrugBank ID | DB00548 |
| Drug Name | Azelaic acid |
| Target ID | BE0000585 |
| UniProt ID | P31213 |
| Regulation Type | inhibitor |
| PubMed IDs | 17139284; 17016423; 3207614 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Stamatiadis D, Bulteau-Portois MC, Mowszowicz I: Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol. 1988 Nov;119(5):627-32. |
| Groups | Approved |
| Direct Classification | Medium-chain fatty acids |
| SMILES | OC(=O)CCCCCCCC(O)=O |
| Pathways | |
| PharmGKB | PA164754850 |
| ChEMBL | CHEMBL1238 |
